BiOxyDyn secures $1.9 million in venture financing - MarketLine Financial Deals

BiOxyDyn secures $1.9 million in venture financing

BiOxyDyn secures $1.9 million in venture financing - MarketLine Financial Deals
BiOxyDyn secures $1.9 million in venture financing
Published Oct 04, 2012
2 pages — Published Oct 04, 2012
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

BiOxyDyn Limited, a UK-based company engaged in the development and application of diagnostic imaging tools and imaging services, has secured GBP1.2 million in venture financing.

  
Source:
Document ID
MA125143_121016
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "BiOxyDyn secures $1.9 million in venture financing" Oct 04, 2012. Alacra Store. Dec 09, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/BiOxyDyn-secures-1-9-million-in-venture-financing-2052-87889>
  
APA:
MarketLine Financial Deals. (2012). BiOxyDyn secures $1.9 million in venture financing Oct 04, 2012. New York, NY: Alacra Store. Retrieved Dec 09, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/BiOxyDyn-secures-1-9-million-in-venture-financing-2052-87889>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.